Novavax (NVAX) Misses Q3 EPS by 1c

Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $9.2 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49